Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort

Introduction. Concern regarding overtreatment of prostate cancer (CaP) is leading to increased attention on active surveillance (AS). This study examined CaP survivors on AS and compared secondary treatment patterns and overall survival by race/ethnicity. Methods. The study population consisted of C...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Cullen, Stephen A. Brassell, Yongmei Chen, Christopher Porter, James L'Esperance, Timothy Brand, David G. McLeod
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2011/234519
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553355127291904
author Jennifer Cullen
Stephen A. Brassell
Yongmei Chen
Christopher Porter
James L'Esperance
Timothy Brand
David G. McLeod
author_facet Jennifer Cullen
Stephen A. Brassell
Yongmei Chen
Christopher Porter
James L'Esperance
Timothy Brand
David G. McLeod
author_sort Jennifer Cullen
collection DOAJ
description Introduction. Concern regarding overtreatment of prostate cancer (CaP) is leading to increased attention on active surveillance (AS). This study examined CaP survivors on AS and compared secondary treatment patterns and overall survival by race/ethnicity. Methods. The study population consisted of CaP patients self-classified as black or white followed on AS in the Center for Prostate Disease Research (CPDR) multicenter national database between 1989 and 2008. Secondary treatment included radical prostatectomy (RP), external beam radiation therapy or brachytherapy (EBRT-Br), and hormone therapy (HT). Secondary treatment patterns and overall survival were compared by race/ethnicity. Results. Among 886 eligible patients, 21% were black. Despite racial differences in risk characteristics and secondary treatment patterns, overall survival was comparable across race. RP following AS was associated with the longest overall survival. Conclusion. Racial disparity in overall survival was not observed in this military health care beneficiary cohort with an equal access to health care.
format Article
id doaj-art-bcac8bb97ead44beb202a63daf004144
institution Kabale University
issn 2090-3111
2090-312X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-bcac8bb97ead44beb202a63daf0041442025-02-03T05:54:20ZengWileyProstate Cancer2090-31112090-312X2011-01-01201110.1155/2011/234519234519Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance CohortJennifer Cullen0Stephen A. Brassell1Yongmei Chen2Christopher Porter3James L'Esperance4Timothy Brand5David G. McLeod6Center for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USACenter for Prostate Disease Research, Department of Defense, Rockville, MD 20852, USAIntroduction. Concern regarding overtreatment of prostate cancer (CaP) is leading to increased attention on active surveillance (AS). This study examined CaP survivors on AS and compared secondary treatment patterns and overall survival by race/ethnicity. Methods. The study population consisted of CaP patients self-classified as black or white followed on AS in the Center for Prostate Disease Research (CPDR) multicenter national database between 1989 and 2008. Secondary treatment included radical prostatectomy (RP), external beam radiation therapy or brachytherapy (EBRT-Br), and hormone therapy (HT). Secondary treatment patterns and overall survival were compared by race/ethnicity. Results. Among 886 eligible patients, 21% were black. Despite racial differences in risk characteristics and secondary treatment patterns, overall survival was comparable across race. RP following AS was associated with the longest overall survival. Conclusion. Racial disparity in overall survival was not observed in this military health care beneficiary cohort with an equal access to health care.http://dx.doi.org/10.1155/2011/234519
spellingShingle Jennifer Cullen
Stephen A. Brassell
Yongmei Chen
Christopher Porter
James L'Esperance
Timothy Brand
David G. McLeod
Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
Prostate Cancer
title Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
title_full Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
title_fullStr Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
title_full_unstemmed Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
title_short Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
title_sort racial ethnic patterns in prostate cancer outcomes in an active surveillance cohort
url http://dx.doi.org/10.1155/2011/234519
work_keys_str_mv AT jennifercullen racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT stephenabrassell racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT yongmeichen racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT christopherporter racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT jameslesperance racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT timothybrand racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort
AT davidgmcleod racialethnicpatternsinprostatecanceroutcomesinanactivesurveillancecohort